<?xml version="1.0" encoding="UTF-8"?>
<record>
  <leader>     cx  r22     2  45  </leader>
  <controlfield tag="001">212500074</controlfield>
  <controlfield tag="003">http://www.idref.fr/212500074</controlfield>
  <controlfield tag="004">20171021</controlfield>
  <controlfield tag="005">20231111014132.000</controlfield>
  <controlfield tag="006">0499</controlfield>
  <controlfield tag="007">0499</controlfield>
  <controlfield tag="008">Tr2</controlfield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="a">20171021afrey50      ba0</subfield>
  </datafield>
  <datafield tag="101" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
    <subfield code="2">639-2</subfield>
  </datafield>
  <datafield tag="103" ind1=" " ind2=" ">
    <subfield code="a"> 1993     </subfield>
  </datafield>
  <datafield tag="104" ind1=" " ind2=" ">
    <subfield code="f">fre</subfield>
  </datafield>
  <datafield tag="106" ind1=" " ind2=" ">
    <subfield code="a">0</subfield>
    <subfield code="b">#</subfield>
    <subfield code="c">#</subfield>
  </datafield>
  <datafield tag="152" ind1=" " ind2=" ">
    <subfield code="a">AFNOR</subfield>
  </datafield>
  <datafield tag="189" ind1=" " ind2=" ">
    <subfield code="a">Oeuvre Textuelle</subfield>
  </datafield>
  <datafield tag="231" ind1=" " ind2=" ">
    <subfield code="7">ba0yba0</subfield>
    <subfield code="a">Drug stereochemistry, analytical methods and pharmacology</subfield>
  </datafield>
  <datafield tag="300" ind1=" " ind2=" ">
    <subfield code="7">ba0yba0y</subfield>
    <subfield code="a">&quot;Updated to reflect modern advances in the techniques and methodology of drug stereochemistry, the Third Edition comprehensively presents all aspects of chiral drugs from scientific, academic, governmental, industrial, and clinical points of view. This stand-alone text covers the lifespan of stereochemistry, from its early history, including an overview of terms and concepts, to the current drug development process, legal and regulatory issues, and the new stereoisomeric drugs. New topics in the Third Edition include: The use of enzymes in the synthesis and resolution of enantiometrically pure compounds in drug discovery; How stereochemistry impacts decisions made in the Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) stages of drug discovery; A chapter on pharmacokinetics and pharmacodynamics that discusses the issues faced during the final stages of the drug development process; The impact of International Conference on Harmonisation on the use of single isomer drugs; Racemic switches; The concept of molecular chiral recognition and how it affects the separation and behavior of stereochemically pure drugs; A chapter on the legal perspectives of patent issues surrounding racemic switches and the marketing of single enantiomer switches&quot;--Provided by publisher</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">04068010X</subfield>
    <subfield code="a">Chimie pharmaceutique</subfield>
    <subfield code="3">040739619</subfield>
    <subfield code="x">Méthodes</subfield>
    <subfield code="2">fmesh</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">040783693</subfield>
    <subfield code="a">Stéréoisomérie</subfield>
    <subfield code="2">fmesh</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">040742008</subfield>
    <subfield code="a">Conformation moléculaire</subfield>
    <subfield code="2">fmesh</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">027815153</subfield>
    <subfield code="a">Stéréochimie</subfield>
    <subfield code="2">rameau</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">028885171</subfield>
    <subfield code="a">Stéréoisomères</subfield>
    <subfield code="2">rameau</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">029408873</subfield>
    <subfield code="a">Médicaments</subfield>
    <subfield code="x">Relations structure-activité</subfield>
    <subfield code="2">rameau</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="3">027797996</subfield>
    <subfield code="a">Chimie pharmaceutique</subfield>
    <subfield code="2">rameau</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">Stereoisomers</subfield>
    <subfield code="2">mesh</subfield>
  </datafield>
  <datafield tag="606" ind1="2" ind2=" ">
    <subfield code="a">Stereoisomerism</subfield>
    <subfield code="2">mesh</subfield>
  </datafield>
  <datafield tag="606" ind1="1" ind2=" ">
    <subfield code="a">Chemistry, Pharmaceutical</subfield>
    <subfield code="x">methods</subfield>
    <subfield code="2">mesh</subfield>
  </datafield>
  <datafield tag="606" ind1="2" ind2=" ">
    <subfield code="a">Molecular Conformation</subfield>
    <subfield code="2">mesh</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">Chiral drugs</subfield>
    <subfield code="2">lc</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">Pharmaceutical chemistry</subfield>
    <subfield code="2">lc</subfield>
  </datafield>
  <datafield tag="606" ind1=" " ind2=" ">
    <subfield code="a">Stereochemistry</subfield>
    <subfield code="2">lc</subfield>
  </datafield>
  <datafield tag="801" ind1=" " ind2="3">
    <subfield code="a">FR</subfield>
    <subfield code="b">Abes</subfield>
    <subfield code="c">20231111</subfield>
    <subfield code="g">AFNOR</subfield>
  </datafield>
</record>

